SPOTLIGHT -
Pharmaceutical Executive, July 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive July 2017 issue in an interactive PDF format.
Santhera Selects Veeva Systems for Product Launch
EFPIA, EBE, and Vaccines Europe Support EU on Combatting AMR
DHL Opens New Life Sciences Facility in Ireland
Poland’s Pharma Market to Reach $11 Billion by 2021
New Survey—Clinical Trials: Past, Present and Future
Brazil’s Pharma Market to Approach “$30 billion by 2021”
mHealth Remains Popular Due to Shift towards Value-Based Medicine
Myeloma UK Announces New CEO
Singapore’s Pharma Market “Set to break $1 billion by 2019”
Keep Compliance Top of Mind
These articles from Pharmaceutical Executive help will help marketers stay on message and, crucially, up to date in a field that is changing faster than ever.
Eli Lilly and NRAS Launch Film for RA Awareness Week
Bright Skies, Big Challenges: Orphan Drugs and Rare Diseases
New EPFIA President Sets Out Vision of "Healthier Future for Europe"
Irvine Scientific Expands R&D Capabilities in Southern California
Painkillers Market “to hit $28.8 billion by 2023”
UK BioIndustry Urges Early Agreement in Brexit Talks Following Surprise Election Outcome
J&J Launches Patient Outcome and Cost-Reducing Approach in EMEA
EuropaBio Calls for More Transparency of Biosimilar Labels
Asia-Pacific Asthma Market “Will Hit $6 billion by 2023”
Pharma’s Reputation Nightmare Gets Marginally Better
New survey ranks the reputation of individual pharmaceutical companies.
Preparing for the Growth of the Biopharma Market
Great Oncology Products Don't "Guarantee Physician Satisfaction"
Customer Experience: A Buzz Term or a Source of Real Commercial Value?
Exploring the importance of a customer experience strategy (CXM) through a case study of a life science tools company.
Gottlieb Takes Reins at FDA, Big Issues Loom
New legislation, administration priorities raise multiple challenges for new commissioner.
EU Countries Square Up to Pharma on Prices
The recent EFPIA and EU health council conferences highlight the growing divisions-and resentments-between industry and governments in Europe.
Pharmaceutical Executive, June 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive June 2017 issue in an interactive PDF format.
US Generics Market Set for More "Dynamic Growth"
FDA Approves Keytruda for Cancers with Specific Biomarker
WHO Names New Director-General
